141 related articles for article (PubMed ID: 8811778)
1. Area of skin disease can be used to indicate amount of treatment needed.
Long CC; Finlay AY
BMJ; 1996 Sep; 313(7058):690. PubMed ID: 8811778
[No Abstract] [Full Text] [Related]
2. [Comments on topical dermatologic treatment].
Taube KM; Wozniak KD
Z Arztl Fortbild (Jena); 1989; 83(6):323-5. PubMed ID: 2735078
[No Abstract] [Full Text] [Related]
3. Tazarotene is an effective therapy for elastosis perforans serpiginosa.
Outland JD; Brown TS; Callen JP
Arch Dermatol; 2002 Feb; 138(2):169-71. PubMed ID: 11843635
[No Abstract] [Full Text] [Related]
4. Effectiveness of topical maxacalcitol for acquired perforating disorder.
Yoshiya H; Okuyama R; Uhara H
J Am Acad Dermatol; 2013 Jun; 68(6):e181-2. PubMed ID: 23680211
[No Abstract] [Full Text] [Related]
5. [Topical treatment of skin diseases of childhood. Part II. Special therapy].
Horáková M
Cesk Pediatr; 1981 Aug; 36(8):470-4. PubMed ID: 7273230
[No Abstract] [Full Text] [Related]
6. Topical treatments.
Pantling L
Nurs Stand; 2013 Nov 20-26; 28(12):61. PubMed ID: 24251517
[No Abstract] [Full Text] [Related]
7. [Urea in topical therapy of skin diseases--principles and use].
Wohlrab WA
Z Arztl Fortbild (Jena); 1993 Aug; 87(8):643-50. PubMed ID: 8379203
[No Abstract] [Full Text] [Related]
8. Topical treatments: a simple guide.
Greenhow MM
Nursing (Lond); 1983 Feb; 2(10):281-4. PubMed ID: 6554497
[No Abstract] [Full Text] [Related]
9. [Special features of topical and systemic dermatologic therapy in children].
Lukas A; Wolf G; Fölster-Holst R
J Dtsch Dermatol Ges; 2006 Aug; 4(8):658-78; quiz 679-80. PubMed ID: 16895569
[No Abstract] [Full Text] [Related]
10. Can we still suggest the topical cyclosporin treatment in cutaneous disorders?
Vena GA; Cassano N
J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):18-9. PubMed ID: 11451314
[No Abstract] [Full Text] [Related]
11. Therapeutic/treatment modalities.
Weber R
Dermatol Nurs; 2005 Aug; 17(4):304-5. PubMed ID: 16206688
[No Abstract] [Full Text] [Related]
12. [External agents for the care and treatment of the skin].
Fröhlich HH
Pharm Unserer Zeit; 1979 Nov; 8(6):179-88. PubMed ID: 538049
[No Abstract] [Full Text] [Related]
13. Viva questions from the IJDVL. Topical corticosteroids.
Viswanath V; Vasani R
Indian J Dermatol Venereol Leprol; 2016; 82(2):240-5. PubMed ID: 26924414
[No Abstract] [Full Text] [Related]
14. Successful treatment of acquired reactive perforating collagenosis with topical benzoyl peroxide: A possible therapeutic action underlying structural and metabolic turnover.
Miyanaga M; Oyama N; Sakai Y; Imamura Y; Hasegawa M
J Dermatol; 2020 Jan; 47(1):e12-e14. PubMed ID: 31599039
[No Abstract] [Full Text] [Related]
15. Dry skin and moisturizers.
Flynn TC; Petros J; Clark RE; Viehman GE
Clin Dermatol; 2001; 19(4):387-92. PubMed ID: 11535378
[No Abstract] [Full Text] [Related]
16. Topical Drug Innovation From 2000 Through 2014.
Walter JR; Xu S
JAMA Dermatol; 2015 Jul; 151(7):792-4. PubMed ID: 25807060
[No Abstract] [Full Text] [Related]
17. Effective topical dermatologic therapy.
Cullen SI
Dermatol Clin; 1989 Jan; 7(1):37-42. PubMed ID: 2646048
[TBL] [Abstract][Full Text] [Related]
18. Topical dermatologic therapy.
McKay M
Prim Care; 1983 Sep; 10(3):513-24. PubMed ID: 6556696
[TBL] [Abstract][Full Text] [Related]
19. Alternative topical therapy.
Litt JZ
Dermatol Clin; 1989 Jan; 7(1):43-52. PubMed ID: 2920464
[TBL] [Abstract][Full Text] [Related]
20. Halobetasol versus clobetasol: a study of potency.
Mohandas S; Rai R; Srinivas CR
Indian J Dermatol Venereol Leprol; 2009; 75(2):186-7. PubMed ID: 19293512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
